Prescription Required
Inclusive of all taxes
In Bacterial infections Bactimox Plus 125mg/125mg Tablet DT is a medicine that effectively treats a wide range of bacterial infections, especially the ones which are suspected to be caused due to resistant bacteria. These infections may include otitis media (ear infection), rhinosinusitis (sinus infection), tonsillitis (infection of tonsils), dental abscess (tooth infection), pneumonia (lung infection), cellulitis (skin infection), and urinary tract infections. The presence of probiotics reduces the chance of side effects like stomach upset or diarrhea associated with prolonged intake of antibiotics. Usually, children start to feel better within 2-3 days of regular dosing. Make sure to finish the recommended course of the medicine as stopping the medicine abruptly may lead to ineffective treatment or may even worsen your child’s condition.
It is not known whether it is safe to consume alcohol with Bactimox Plus 125mg/125mg Tablet DT. Please consult your doctor.
Information regarding the use of Bactimox Plus 125mg/125mg Tablet DT during pregnancy is not available. Please consult your doctor.
Bactimox Plus 125mg/125mg Tablet DT is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Bactimox Plus 125mg/125mg Tablet DT does not usually affect your ability to drive.
Bactimox Plus 125mg/125mg Tablet DT should be used with caution in patients with kidney disease. Dose adjustment of Bactimox Plus 125mg/125mg Tablet DT may be needed. Please consult your doctor.
Bactimox Plus 125mg/125mg Tablet DT is safe to use in patients with liver disease. No dose adjustment of Bactimox Plus 125mg/125mg Tablet DT is recommended.
Unless your child’s doctor has advised a specific regime for your child, you can give the missed dose as soon as you remember. Skip the missed dose if it is almost time for the next dose. Do not give a double dose to catch up and follow the prescribed dosing schedule.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More